XML 42 R30.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2024
Stockholders' Equity Note [Abstract]  
Stock-based Compensation Expense
The stock-based compensation related to our stock-based awards and employee stock purchase plan for the three and six months ended June 30, 2024 and 2023 is as follows (in thousands):
 Three Months Ended
June 30,
Six Months Ended
June 30,
 2024202320242023
Cost of net revenues$2,582 $1,901 $4,646 $3,708 
Selling, general and administrative34,274 29,002 62,768 57,693 
Research and development10,172 6,957 18,402 14,194 
Total stock-based compensation$47,028 $37,860 $85,816 $75,595 
Summary Of Restricted Stock Units A summary for the six months ended June 30, 2024 is as follows:
Number of Shares
Underlying RSUs
(in thousands)
Weighted Average Grant Date Fair ValueWeighted Average Remaining
Contractual Term (in years)
Aggregate
Intrinsic Value
(in thousands)
Unvested as of December 31, 2023
736 $367.63 
Granted
631 310.21 
Vested and released(249)370.60 
Forfeited(34)360.58 
Unvested as of June 30, 2024
1,084 $333.79 1.8$261,797 
Summary Of Market-performance Based Restricted Stock Units
The following table summarizes the MSU performance activity for the six months ended June 30, 2024: 
Number of Shares
Underlying MSUs
(in thousands)
Weighted Average Grant Date Fair Value
Weighted Average
Remaining
Contractual Term (in years)
Aggregate
Intrinsic Value
(in thousands)
Unvested as of December 31, 2023
158 $811.06 
Granted83 617.79 
Vested and released 1
(32)1,102.09 
Forfeited(5)1,102.09 
Unvested as of June 30, 2024
204 $679.52 1.9$49,247 
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The fair value of the option component of the 2010 Purchase Plan shares was estimated at the grant date using the Black-Scholes option pricing model with the following weighted average assumptions:
 Six Months Ended
June 30,
 20242023
Expected term (in years)0.91.0
Expected volatility56.0 %56.7 %
Risk-free interest rate4.8 %4.6 %
Expected dividends— — 
Weighted average fair value at grant date$100.10 $105.75